Ophthalmic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Retinitis Pigmentosa Gene Therapy: Orphan Drug

The FDA has granted Orphan Drug designation to RST-001 for the treatment of retinitis pigmentosa (RP).

Reading Glasses Obsolete with Implantable Device? ...

A new implantable eye device might make reading glasses a thing of the past.

Telescope Implant for AMD Use Expanded

The FDA has approved the Implantable Miniature Telescope for patients with bilateral end-stage age-related macular degeneration (AMD) aged ≥65 years.

Stem Cells for Macular Dystrophy, Degeneration

A new study is the first to show the long-term safety of embryonic stem cell transplants to treat human disease, including Stargardt's macular dystrophy and dry atrophic age-related macular degeneration.

Ozurdex Granted General DME Indication

The FDA has approved Ozurdex (dexamethasone intravitreal implant) for the treatment of diabetic macular edema (DME).

CDC: Children Need Vision Care

Millions of infants and children aren't receiving recommended medical care aimed at detecting and preventing disease, including vision screenings.

Eylea Gains New Indication

FDA has approved Eylea (aflibercept) injection for the treatment of diabetic macular edema (DME).

Chart: Bacterial Conjunctivitis Treatments

Review this chart on Bacterial Conjunctivitis Treatments for quick information when you need it.


Telemedicine Screening Could Help ID Diabetic Retinopathy

Use of a nonmydriatic camera for retinal imaging combined with the remote evaluation of images identifies diabetic retinopathy (DR) in about 20% of patients with diabetes.

Investigational Night Blindness Drug Designated Breakthrough Therapy

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to SPK-RPE65 (Spark Therapeutics) for the treatment of nyctalopis, or night blindness, in patients with Leber's congenital amaurosis due to mutations in the RPE65 gene.

Google Glass May Cause Blind Spots in Vision

A small new study suggests that the structure of Google Glass (rather than the software) may curtail natural peripheral vision, creating blind spots that undermine safety while engaging in routine tasks, such as driving or walking.

Clinical Charts

Make prescribing decisions with our charts and treatment algorithms.

Featured courses from mycme

Clinical review - Colorectal cancerExternal web site

Clinical review - Colorectal cancer

2.50 Credits

Pulmonology, Pediatrics, Ophthalmology, and ENTExternal web site

This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...

CME 5.00 Credits

MediBrief: A Yearly Review of Diabetic Macular EdemaExternal web site

PracticeSM from Primary to Specialty Care is a certified, opt-in, educational activity that briefly provides ...

CME 1.00 Credits

Sign Up for Free e-newsletters